"The availability of these kits will help determine exposure to Zika virus in humans and animals and allow for rapid testing of various Zika vaccines," said Dr. Masarrat Ali, Director of Research and Development at ADI
San Antonio, Texas (PRWEB) March 04, 2016
San Antonio, Texas-based biotech company Alpha Diagnostic International, Inc (ADI) has developed several ELISA test kits for the detection of major Zika viral protein antibodies (Capsid, Envelope, prM, and NS1). The ELISA kits are available for humans as well as monkeys and mice that can be readily used in ongoing research and vaccine development projects on animal models of disease. For more details, please visit:
The World Health Organization (WHO) has declared Zika virus as an international public health emergency, prompted by growing concerns that it may cause severe birth defects (microcephaly). ADI was the first company to release Ebola and MERS ELISA kits, which played a major role in the testing and development of vaccines for these emerging diseases. ADI has again responded promptly to the Zika virus threat by cloning and expressing several key antigenic proteins from Zika virus (Capsid, Envelope, prM, and NS1) and raising antibodies to these Zika proteins for the development of antibody ELISA kits. These ELISA kits have high sensitivity and require only a tiny drop of blood or serum to conduct the test. Within two hours, results are clearly evident through a visual color change and can also provide quantitative data. The ADI Zika virus detection ELISA kits are for research use only (RUO). "The availability of these kits will help determine exposure to Zika virus in humans and animals and allow for rapid testing of various Zika vaccines," said Dr. Masarrat Ali, Director of Research and Development at ADI. Zika virus belongs to the Flavivirus genus which consists of West Nile virus, Japanese Encephalitis virus, Yellow Fever virus, Dengue virus, and Tick-Borne Encephalitis virus. ADI has antibody ELISA kits available for of all these related viruses.
ADI is the first company to develop a number of Zika virus ELISA detection kits and is currently developing Zika virus antigen and antibody rapid tests. The rapid tests will help to quickly identify potential exposure to the virus in field or remote area testing applications. ADI has opened communications with CDC and health officials in the State of Texas for donating some of the ELISA kits to enable immediate testing needs.
About Alpha Diagnostic International, Inc. (ADI)
ADI is a privately held, U.S. biotechnology company headquartered in San Antonio, Texas. ADI develops, manufactures, and supplies novel diagnostic and quality control reagents and test kits for use in basic biological and disease research in humans and animals. An important mission of ADI is to develop and supply diagnostic and validating solutions for promoting global health through improved vaccine therapeutics and mitigating the spread of human and animal diseases.
Alpha Diagnostic Int’l, Inc.
6203 Woodlake Center
San Antonio, Texas 78244
Toll Free: (800)-786-5777
Office: (210) 561-9515 Fax: (210) 561-9544